| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.035 | 0.2 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.038 | 0.2 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.2 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |